IT8521654A0 - Formulazioni topiche a lento rilascio. - Google Patents

Formulazioni topiche a lento rilascio.

Info

Publication number
IT8521654A0
IT8521654A0 IT8521654A IT2165485A IT8521654A0 IT 8521654 A0 IT8521654 A0 IT 8521654A0 IT 8521654 A IT8521654 A IT 8521654A IT 2165485 A IT2165485 A IT 2165485A IT 8521654 A0 IT8521654 A0 IT 8521654A0
Authority
IT
Italy
Prior art keywords
slow release
topical formulations
release topical
formulations
slow
Prior art date
Application number
IT8521654A
Other languages
English (en)
Other versions
IT1201436B (it
Inventor
Zappia Vincenzo
Mario De Rosa
Original Assignee
Napoli Zappia Vincenzo A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napoli Zappia Vincenzo A filed Critical Napoli Zappia Vincenzo A
Priority to IT21654/85A priority Critical patent/IT1201436B/it
Publication of IT8521654A0 publication Critical patent/IT8521654A0/it
Priority to DE8686109454T priority patent/DE3681529D1/de
Priority to EP86109454A priority patent/EP0211268B1/en
Priority to DE198686109454T priority patent/DE211268T1/de
Priority to AT86109454T priority patent/ATE67488T1/de
Priority to JP61170714A priority patent/JPS6236367A/ja
Application granted granted Critical
Publication of IT1201436B publication Critical patent/IT1201436B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT21654/85A 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio IT1201436B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio
DE8686109454T DE3681529D1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
EP86109454A EP0211268B1 (en) 1985-07-19 1986-07-10 Slow-release topical formulations
DE198686109454T DE211268T1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
AT86109454T ATE67488T1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
JP61170714A JPS6236367A (ja) 1985-07-19 1986-07-18 ミノキシジル塩、その製法およびそれを有効成分とする外用剤または化粧料

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio

Publications (2)

Publication Number Publication Date
IT8521654A0 true IT8521654A0 (it) 1985-07-19
IT1201436B IT1201436B (it) 1989-02-02

Family

ID=11184897

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio

Country Status (5)

Country Link
EP (1) EP0211268B1 (it)
JP (1) JPS6236367A (it)
AT (1) ATE67488T1 (it)
DE (2) DE211268T1 (it)
IT (1) IT1201436B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86547A1 (fr) * 1986-08-07 1988-03-02 Oreal Suspension pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
JPS63186560A (ja) * 1987-05-15 1988-08-02 Toshiba Corp 電圧共振形高周波スイッチング回路
LU86958A1 (fr) * 1987-07-31 1989-03-08 Oreal Sels d'acide thiamorpholinone carboxylique et de derives de diamino-2,4 pyrimidine,leur utilisation en cosmetique et pharmacie
EP0330453A1 (en) * 1988-02-26 1989-08-30 Minnesota Mining And Manufacturing Company Scalp treatment composition
DE3816995A1 (de) * 1988-05-19 1989-11-23 Hoechst Ag Verwendung von pyrimido-(6,1-a)-isochinolin-4-on-derivaten und medizinische zubereitungen auf basis dieser verbindungen
JP2744853B2 (ja) * 1991-03-29 1998-04-28 品川白煉瓦株式会社 スライドバルブ装置用プレート煉瓦カートリッジ及び該カートリッジを用いたスライドバルブ装置
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
EP0764169B1 (en) * 1994-06-10 1998-09-23 Dumex-Alpharma A/S Drug salts
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
DE102005060690B4 (de) * 2005-12-15 2008-09-25 Capsulution Nanoscience Ag Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen
JP5323324B2 (ja) * 2007-04-13 2013-10-23 大正製薬株式会社 ミノキシジル配合育毛剤の着色防止方法及びミノキシジル配合育毛剤が充填された容器
JP2013536884A (ja) 2010-08-31 2013-09-26 ビーエーエスエフ ソシエタス・ヨーロピア クエン酸に基づいた分枝ポリエステル、さらにはそれらの製造及び使用
JP6914917B2 (ja) 2015-08-21 2021-08-04 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 活性成分とポリマー性対イオンとの塩
JP6914916B2 (ja) 2015-08-21 2021-08-04 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ Ｎ−ビニルピロリドン及びアクリル酸をベースとした水溶性ポリマーの医薬助剤としての使用
MX2018001546A (es) 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE560809A (it) *
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE3280344D1 (de) * 1981-11-09 1991-07-25 Gail S Bazzano Verwendung von retinoiden und minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxid) zur verbesserung des wachstums von menschlichem kopfhaar und zur behandlung bestimmter typen von alopecia.
NZ214397A (en) * 1984-12-21 1989-04-26 Richardson Vicks Inc Minoxidil and acrylate polymer topical compositions

Also Published As

Publication number Publication date
EP0211268B1 (en) 1991-09-18
EP0211268A3 (en) 1988-01-20
DE211268T1 (de) 1987-08-13
JPS6236367A (ja) 1987-02-17
EP0211268A2 (en) 1987-02-25
IT1201436B (it) 1989-02-02
DE3681529D1 (de) 1991-10-24
ATE67488T1 (de) 1991-10-15

Similar Documents

Publication Publication Date Title
DE3677276D1 (de) Photopolymerisierbare zusammensetzung.
FI873109A0 (fi) Buren polymerisationskatalysator.
DE3672434D1 (de) Trennmittelabgabeelement.
DE3667244D1 (de) Wundklammer.
DE3677326D1 (de) Zapfpumpe.
DE3679167D1 (de) Drehlager.
PT83499A (pt) Mecanismo agrafador
IT8521654A0 (it) Formulazioni topiche a lento rilascio.
DE3678517D1 (de) Externum.
FI873023A0 (fi) Ledande flaensar foer roertaetningar.
FI864634A (fi) Flytande diskmedel foer diskning foer hand i kallt vatten.
DE3688642D1 (de) Fdm-tdm-transmultiplexer.
FI863693A0 (fi) Ur sulfatsvartlut haerledd fuktande komposition.
DE3680606D1 (de) Loetapparat.
DE3665304D1 (de) Obelmycin a
DE3668674D1 (de) Bremsvorrichtung.
NO862089L (no) Fortykker.
DE3670211D1 (de) Skibremse.
IT211981Z2 (it) Calibro a corsoio.
DK212786A (da) 1,3-dioxanethere
DE3681550D1 (de) 3-perfluoralkyl-5-hydroxy-isoxazole.
FI871056A0 (fi) Taendroer foer projektil.
NO901018D0 (no) Topisk hematopofyrin.
KR870000373U (ko) 완력기
IT1190646B (it) 2,4-dicloro-5-nitro-tiazolo